Related Experiment Video
Updated: Feb 8, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes
Darsana Viswam1, Simon Trotter2, P Sherwood Burge1
1Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham, UK.
Vaping e-cigarettes containing vegetable glycerine caused lipoid pneumonia in a young woman. Continued vaping despite medical advice led to persistent respiratory issues, highlighting vaping risks.
Area of Science:
- Pulmonology
- Toxicology
Background:
- E-cigarette (EC) use is increasing, with potential unknown health consequences.
- Lipoid pneumonia is a rare lung disease caused by aspiration of lipids.
Observation:
- A young female vaper presented with respiratory failure, cough, dyspnea, fever, and night sweats.
- Imaging revealed diffuse ground-glass infiltrates; bronchoscopy was unyielding.
- Video-assisted thoracoscopic surgical biopsy confirmed lipoid pneumonia.
Findings:
- The patient's lipoid pneumonia was linked to vegetable glycerine in e-cigarettes.
- Initial steroid treatment improved oxygenation, but symptoms persisted with continued vaping.
- Clinical and spirometric parameters showed no significant improvement despite cessation advice.
Implications:
- E-cigarette ingredients, like vegetable glycerine, can cause severe lung injury.
- Lipoid pneumonia should be considered in vapers with unexplained respiratory symptoms.
- Further research is needed on the long-term pulmonary effects of e-cigarette use.
Related Concept Videos
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV
Acute Respiratory Failure-III
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

